Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer.

Journal: PLOS Genetics

Published: 2020-02-03

DOI: 10.1371/journal.pgen.1008572

Affiliations: 5

Authors: 6

Go to article
Institutions Share
School of Biomedical Sciences, HKU, China 0.33
Faculty of Medicine, University of Helsinki, Finland 0.33
Prince of Wales Clinical School (POWCS), UNSW Sydney, Australia 0.17
Children's Medical Research Institute (CMRI), Australia 0.17